Related Experiment Video
Updated: Jun 14, 2026
07:08
Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Optical small animal imaging in the drug discovery process
Biochimica Et Biophysica Acta
|March 30, 2010
Summary
This review covers optical imaging techniques and molecular probes for preclinical cancer research. It highlights advances in rodent tumor imaging for developing new cancer therapies.
Area of Science:
- Oncology
- Biomedical Imaging
- Preclinical Research
Background:
- Molecular imaging is crucial for advancing cancer treatment development.
- Rapid progress in optical imaging technologies and molecular probes is transforming in vivo studies.
- Rodent models are essential for evaluating novel cancer therapies.
Purpose of the Study:
- To provide an overview of rodent imaging modalities for cancer research.
- To focus on optical probes utilized in preclinical cancer imaging.
- To summarize recent advancements in molecular imaging for oncology.
Main Methods:
- Review of current literature on optical imaging techniques.
- Analysis of molecular probes for in vivo tumor detection.
- Focus on modalities applicable to rodent models.
Main Results:
- Identification of key optical imaging modalities for preclinical cancer studies.
- Description of various molecular probes and their applications.
- Highlighting the importance of in vivo imaging in drug development.
Conclusions:
- Optical imaging and molecular probes are vital tools in preclinical cancer research.
- Continued innovation in this field accelerates the development of novel cancer treatments.
- Rodent models provide a critical platform for translating imaging advancements.
